TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Bod Australia Ltd ( (AU:BOD) ) has issued an update.
Bod Science Limited is undergoing significant changes as it continues to operate under a Deed of Company Arrangement (DOCA) with Biortica Agrimed Limited. Due to delays in meeting certain conditions, the company is expected to be delisted from the ASX, and a proposed reverse takeover will not proceed. A Variation of DOCA proposal, which includes a potential compulsory acquisition of shares by Biortica, will be considered by the company’s creditors. If successful, this could lead to a capital loss declaration for shareholders, marking a pivotal moment in the company’s restructuring efforts.
More about Bod Australia Ltd
Bod Science Limited, formerly known as Bod Australia Limited, operates in the pharmaceutical industry. The company focuses on developing and distributing health and wellness products, with a particular emphasis on innovative cannabis-based products.
Technical Sentiment Signal: Sell
Current Market Cap: A$4.26M
Learn more about BOD stock on TipRanks’ Stock Analysis page.